Medicine

Li Zhang, PhD

Associate Professor
Medicine

Li Zhang, PhD is an Associate Professor in the UCSF Department of Medicine and Department of Epidemiology and Biostatistics. She is an associate member of the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC). Professor Zhang has over 15 years of experience in applying statistical methods in medical research, including epidemiology studies, basic science studies, clinical trials design, and high-throughput sequencing data. Her statistical methodological interests are cancer epidemiology and immunoinformatics. Currently, Professor Zhang serves on the Global Action Plan 6 Project Steering Committee for the Movember Foundation and the American Society of Clinical Oncology Career Development Award as a statistical reviewer. She has more than 60 publications. 

Geoffrey Buckle, MD, MPH

Clinical Instructor
Medicine

Dr. Geoffrey Buckle is a physicial trained in internal medicine and public health who conducts research on strategies to improve the delivery of cancer care in resource-limited settings. He is a Clinical Instructor at UCSF and is currently splitting his time serving as a Hospitalist on the UCSF Bone Marrow Transplant Service and conducting research with the UCSF Global Cancer Program and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania. He has been actively involved in research and program development in the field of global oncology since 2010. His research has focused on examining barriers to diagnosis and management of malignancies in this context, including prior work on endemic Burkitt lymphoma in Kenya and Uganda, cervical cancer in India, and more recently, esophageal cancer in East Africa with the UCSF Global Cancer Program and the African Esophageal Cancer Consortium (AfrECC). Geoffrey graduated from Colby College, received his MPH from Johns Hopkins Bloomberg School of Public Health and his MD from UMass Medical School, and recently completed the UCSF Internal Medicine Residency Program and Program in Residency Investigational Methods and Epidemiology (PRIME). 

Joel Palefsky, MD

Professor of Medicine
Medicine

Dr. Palefsky is a professor in the Department of Infectious Diseases at the UCSF School of Medicine. He is founder and chair of the HPV Working Group of the NCI AIDS Malignancy Consortium and the head of the AMC HPV Virology Core Lab. He is the protocol chair of the ANCHOR study, an eight-year, 15-site NCI/NIH-funded randomized controlled trial designed to determine whether treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in HIV-infected men and women. As the founder and director of the Anal Neoplasia Clinic, Research and Education Center at UCSF, he oversees training of clinicians from around the world in high-resolution anoscopy, anal biopsy, and office-based treatment. He has an active international research program, including studies in India, Costa Rica and Thailand. He is the principal investigator of several laboratory-based and clinical research studies of HPV-associated neoplasia, particularly in the setting of HIV infection.

Stanton Glantz, PhD

Professor of Medicine
Medicine

RESEARCH INTERESTS: Dr. Glantz, the Truth Initiative Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include e-cigarettes and marijuana, both of which are expanding the tobacco epidemic.

Michael Potter, MD

Professor
Medicine

Dr. Potter is a professor in the School of Medicine, director of the San Francisco Bay Area Collaborative Research Network (SFBayCRN) and associate director for Practice-Based Research in the CTSI Community Engagement and Health Policy Program. SFBayCRN is UCSF's primary healthcare practice based research network, with participation from the UCSF Schools of Medicine, Nursing, Pharmacy, and Dentistry. Dr. Potter’s current work focuses on interventions to increase cancer screening rates and enhance self-management support for chronic illnesses such as diabetes and sickle cell disease.  He is co-chair of the Professional Education and Practice Implementation task group for the National Colorectal Cancer Roundtable and co-leads the colorectal cancer task group for the San Francisco Cancer Initiative.  He recently served as faculty for a dissemination and implementation training program jointly sponsored by the governments of Argentina and the United States. 

Paul Volberding, MD

Professor
Medicine

Dr. Volberding is a professor of medicine at UCSF. He is the co-director of the UCSF-Gladstone Center for AIDS Research, an NIH-funded program that supports a large variety of HIV related research across the entire University. As an oncologist, Dr. Volberding has a career-long interest in HIV-associated cancers including those common in resource limited settings. CFAR provides scientific core, mentoring and pilot research grants and work in international sites, especially in East Africa is central to the CFAR mission. Dr. Volberding is also an active supporter of the Infectious Diseases Institute in Kampala, Uganda which is a large and growing part of Makerere University. The IDI provides research training to promising young Ugandan scientists including those engaged in cancer-related research.

Marc Shuman, MD

PROFESSOR EMERITUS
Medicine

Maria Ekstrand, PhD

Professor
Medicine

Dr. Ekstrand is professor of Medicine in the Prevention Science Division at the UCSF School of Medicine and Adjunct Professor at UC Berkeley School of Public Health and the St John’s Research Institute of the St. John’s National Academy of Health Sciences in Bangalore, India. Her primary research interests include measuring and improving treatment adherence and the role of stigma in global health, with a focus on HIV, mental health, cancer and pain control. She is currently PI or MPI of five NIH R01 awards in India and is in the process of starting an India research program in palliative medicine, in collaboration with researchers from St John’s Medical College in Bangalore and the Cicely Saunders Institute of Palliative Care at Kings College, London.

John Ziegler

Professor Emeritus
Medicine

Dr. John Zeigler is Professor Emeritus in the UCSF School of Medicine. In 1967, Dr. Ziegler began a long collaboration with Makerere University in Kampala, Uganda, studying Burkitts lymphoma and other indigenous cancers. Together with Ugandan counterparts, he developed curative therapies for lymphoma and established the Uganda Cancer Institute that today has expanded to a major center of excellence in sub-Saharan Africa under Ugandan leadership. He was recipient of the Albert Lasker Clinical Medical Research Award in 1972 for his outstanding contribution in increasing the cure rate of Burkitt's tumor by chemotherapy. During the early years of the AIDS pandemic, Ziegler and colleagues made important contributions to this field both in California and in Uganda through discovery of viral causes of Burkitt’s lymphoma and Kaposi sarcoma. Dr. Ziegler was the Founding Director of the Masters Degree Program in Global Health at UCSF. As an Emeritus Professor, he has remained active in teaching oncology and global health at UCSF.

Laura Fejerman, PhD

Associate Professor
Medicine

Dr. Fejerman is an associate professor at the UCSF Department of Medicine. She focuses on the discovery of genetic and non-genetic factors that contribute to breast cancer risk and prognosis in Latinas. Her past work established a relationship between genetic ancestry and breast cancer risk, where higher European ancestry in U.S. and Mexican Latinas was associated with an increased risk. Her subsequent research has built upon this observation, exploring genetic variants, through admixture mapping and genome-wide association approaches, as well as the possible environmental and lifestyle related factors, and ancestry-gene interactions. Recent work explores disparities in breast cancer prognosis by genetic ancestry in Latinas and its potential causes.